Pathogenic role of S100A8 and S100A9 alarmins in Coxsackievirus B3-induced myocarditis

被引：0
|
作者：
Mueller, I. [1 ]
Van Linthout, S. [1 ]
Vogl, T. [2 ]
Pieske, B. [3 ]
Tschoepe, C. [3 ]
机构：
[1] Charite Campus Virchow Klinikum CVK, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany
[2] Univ Munster, Dept Immunol, Munster, Germany
[3] Charite Campus Virchow Klinikum CVK, Dept Cardiol & Pulmonol, Berlin, Germany
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6499
引用
收藏
页码：1365 / 1365
页数：1
相关论文
共 50 条
  • [1] Role of S100A8 and S100A9 alarmins in Coxsackievirus B3-induced myocarditis
    Mueller, I.
    Van Linthout, S.
    Vogl, T.
    Pieske, B.
    Tschoepe, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 137 - 138
  • [2] ROLE OF S100A8 AND S100A9 ALARMINS IN COXSACKIEVIRUS B3-INDUCED MYOCARDITIS
    Tschoepe, Carsten
    Mueller, Irene
    Vogl, Thomas
    Pieske, Burkert
    Van Linthout, Sophie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1398 - 1398
  • [3] Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis
    Mueller, Irene
    Vogl, Thomas
    Pappritz, Kathleen
    Miteva, Kapka
    Savvatis, Konstantinos
    Rohde, David
    Most, Patrick
    Lassner, Dirk
    Pieske, Burkert
    Kuehl, Uwe
    Van Linthout, Sophie
    Tschoepe, Carsten
    CIRCULATION-HEART FAILURE, 2017, 10 (11)
  • [4] The alarmins S100A8 and S100A9 mediate acute pain in experimental synovitis
    Arjen B. Blom
    Martijn H. van den Bosch
    Esmeralda N. Blaney Davidson
    Johannes Roth
    Thomas Vogl
    Fons A. van de Loo
    Marije Koenders
    Peter M. van der Kraan
    Edwin J. Geven
    Peter L. van Lent
    Arthritis Research & Therapy, 22
  • [5] The alarmins S100A8 and S100A9 mediate acute pain in experimental synovitis
    Blom, Arjen B.
    van den Bosch, Martijn H.
    Davidson, Esmeralda N. Blaney
    Roth, Johannes
    Vogl, Thomas
    van de Loo, Fons A.
    Koenders, Marije
    van der Kraan, Peter M.
    Geven, Edwin J.
    van Lent, Peter L.
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [6] ALARMINS S100A8 AND S100A9 MODULATE THE INFLAMMATORY MICROENVIRONMENT IN EARLY TENDINOPATHY
    Crowe, L. A. N.
    Akbar, M.
    Patommel, K.
    Kitson, S. M.
    Melchor, E. Garcia
    Gilchrist, D. S.
    Murrell, G. A.
    McInnes, I. B.
    Millar, N. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1232 - 1232
  • [7] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [8] ALARMINS S100A8 AND S100A9 SKEW CHONDROCYTES TOWARDS A CARTILAGE BREAKDOWN PHENOTYPE
    Schelbergen, R. F. P.
    van Lent, P. L. E. M.
    Blom, A. B.
    Sloetjes, A.
    Vogl, T.
    Roth, J.
    van den Berg, W. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 : A44 - A44
  • [9] Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
    Mueller, Irene
    Vogl, Thomas
    Kuehl, Uwe
    Krannich, Alexander
    Banks, Aron
    Trippel, Tobias
    Noutsias, Michel
    Maisel, Alan S.
    van Linthout, Sophie
    Tschoepe, Carsten
    ESC HEART FAILURE, 2020, 7 (04): : 1442 - 1451
  • [10] S100A8/S100A9 alarmin as a potential biomarker in patients with active myocarditis
    Mueller, I.
    Kuehl, U.
    Vogl, T.
    Pieske, B.
    Van Linthout, S.
    Tschoepe, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 313 - 313
12345